{
    "2021-12-29": [
        [
            {
                "time": "2022-12-28",
                "original_text": "A股融资融券日报：两融余额增加34.59亿元（12月28日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "A股",
                        "融资融券"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-28",
                "original_text": "医药生物：关注年报业绩预告有望高增长公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报",
                        "业绩预告",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-12-28",
                "original_text": "西南证券医药2022年度策略：未来医药估值有望均衡，“穿越医保”和“疫情脱敏”是两条核心主线",
                "features": {
                    "keywords": [
                        "西南证券",
                        "医药",
                        "估值均衡",
                        "穿越医保",
                        "疫情脱敏"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-31",
                "original_text": "2021年，国家药品集采转向常态化运行，重塑整个市场格局——“灵魂砍价”一再上演 集采倒逼中国医药行业增添“原创”成色",
                "features": {
                    "keywords": [
                        "国家药品集采",
                        "常态化",
                        "灵魂砍价",
                        "医药行业",
                        "原创"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}